ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 33 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 109 | -99.7% | 0.00% | – |
| Q4 2016 | $25,000 | -19.4% | 38,352 | +286.9% | 0.00% | – |
| Q3 2016 | $31,000 | +14.8% | 9,912 | +11.9% | 0.00% | – |
| Q2 2016 | $27,000 | -80.1% | 8,854 | -76.5% | 0.00% | – |
| Q1 2016 | $136,000 | +189.4% | 37,721 | +272.7% | 0.00% | – |
| Q4 2015 | $47,000 | +683.3% | 10,121 | +951.0% | 0.00% | – |
| Q3 2015 | $6,000 | 0.0% | 963 | +43.1% | 0.00% | – |
| Q2 2015 | $6,000 | +200.0% | 673 | -54.6% | 0.00% | – |
| Q4 2014 | $2,000 | -94.1% | 1,483 | -91.5% | 0.00% | – |
| Q3 2014 | $34,000 | -43.3% | 17,500 | -1.4% | 0.00% | – |
| Q2 2014 | $60,000 | +1.7% | 17,753 | +1.4% | 0.00% | – |
| Q1 2014 | $59,000 | +9.3% | 17,500 | 0.0% | 0.00% | – |
| Q4 2013 | $54,000 | -22.9% | 17,500 | 0.0% | 0.00% | – |
| Q3 2013 | $70,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 2,535,564 | $7,835,000 | 4.00% |
| ProQuest Associates IV LLC | 1,900,000 | $5,871,000 | 2.39% |
| Abingworth LLP | 437,994 | $1,349,000 | 1.41% |
| Hilltop Park Associates LLC | 75,000 | $232,000 | 0.97% |
| Broadfin Capital, LLC | 1,154,674 | $3,568,000 | 0.35% |
| Perceptive Advisors | 1,492,156 | $4,611,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $927,000 | 0.16% |
| Rock Springs Capital Management LP | 450,000 | $1,391,000 | 0.10% |
| WEXFORD CAPITAL LP | 145,622 | $450,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,960 | $49,000 | 0.02% |